… The isolated late increase in distant metastatic disease observed in low-risk patients in
the … to distant metastasis takes many years, reflecting the natural history of the disease. …

… distant metastasis. These jactors have identified patients in the low-risk group with excellent
prognosis and the high-risk … However, some patientsjall within the intermediate-risk category …

… , the use of chemotherapy benefited the intermediate-risk group with an absolute decline of
6.7% in the 5-year DM rate (P = 0.025). Therefore, for the intermediate-risk group, the current …

… and accurately predicted the 5-year risk of distant metastases with a c-Index of 0.76…
intermediate risk disease, the 26% with a high GC score (>0.6) had a 5-year risk of distant metastasis …

… (NCCN) intermediate-risk and high-risk disease, respectively, … failure (FFBF) and freedom
from distant metastasis. … ), and a 7-year freedom from distant metastasis of 100%, 100%, and 82…

… This study aimed to identify such predictors of subsequent distant metastasis and death …
We also aimed to categorize patients according to the risk of subsequent distant metastasis as …

… relapse-free outcomes with higher dose for intermediate- and unfavorable-risk features. In
addition, we now observe decreased rates of distant metastases with higher radiation doses, …

… variables into risk categories (low, intermediate, and high risk), we were able to show that
high-risk tumors had an almost threefold increased risk of DM compared with low-risk tumors. …

… and reduction in distant metastases. The use of short-course ADT in conjunction with RT
improved long-term PSA-RFS and DMFS in intermediate- and high-risk patients; however, an …

… level of risk in predicting the presence of metastatic lesions … and distant metastases, 2/3
cases with lung metastases (1 LR … at least the doubt of metastatic disease and bring the clinician …